Cite
HARVARD Citation
Heong, V. et al. (n.d.). 275PEfficacy and tolerability of olaparib in Asian patients with recurrent ovarian, primary peritoneal or fallopian tube carcinoma: The National University Cancer Institute, Singapore experience. Annals of oncology. p. . [Online].